CTNM insider plans sale of 9,520 common shares

CTNM insider Daniel Lorrain has filed to sell common stock under Form 144.

Rhea-AI Filing Summary

CTNM insider Daniel Lorrain has filed to sell common stock under Form 144. The planned sale involves 9,520 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on August 3, 2026 on NASDAQ.

The shares relate to equity awards including 4,170 restricted stock units granted on May 9, 2017 and an exercise of stock options for 5,350 shares dated August 3, 2026, with cash as the payment method for the option exercise. The filing also lists recent Rule 10b5-1 plan sales of CTNM common stock by Lorrain over the prior three months in multiple tranches.

Key Figures

Planned shares to be sold: 9,520 shares Restricted stock units: 4,170 units Stock options exercised: 5,350 shares +3 more

6 metrics

Planned shares to be sold 9,520 shares Common stock sale planned for August 3, 2026 on NASDAQ

Restricted stock units 4,170 units Restricted Stock Units granted on May 9, 2017 as source of shares

Stock options exercised 5,350 shares Exercise of stock options dated August 3, 2026 with cash payment

June 30, 2026 10b5-1 sale 28,826 shares; $462,288.02 CTNM common stock sold under Rule 10b5-1 on June 30, 2026

July 1, 2026 10b5-1 sale 8,353 shares; $132,290.08 CTNM common stock sold under Rule 10b5-1 on July 1, 2026

June 1, 2026 10b5-1 sale 4,170 shares; $54,862.19 CTNM common stock sold under Rule 10b5-1 on June 1, 2026

Key Terms

Form 144, Rule 10b5-1, Restricted Stock Units, Exercise of Stock Options

4 terms

Form 144 regulatory

"insider Daniel Lorrain has filed to sell common stock under Form 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 10b5-1 regulatory

"The filing also lists recent Rule 10b5-1 plan sales of CTNM common stock"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Restricted Stock Units financial

"Restricted Stock Units granted on May 9, 2017 as source of shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise of Stock Options financial

"Exercise of Stock Options for 5,350 shares dated August 3, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CTNM's Form 144 filing by Daniel Lorrain disclose?

The Form 144 filing discloses that Daniel Lorrain plans to sell 9,520 CTNM common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on August 3, 2026, with sales to be executed on NASDAQ.

How many CTNM shares is Daniel Lorrain planning to sell under this Form 144?

The filing indicates a proposed sale of 9,520 CTNM common shares. These shares are associated with prior equity awards, including restricted stock units and an exercise of stock options scheduled for August 3, 2026.

What equity awards underlie the CTNM shares in Daniel Lorrain's Form 144?

The shares in the Form 144 are tied to 4,170 restricted stock units granted on May 9, 2017 and an exercise of stock options for 5,350 shares dated August 3, 2026, with the option exercise designated as paid in cash.

What recent CTNM stock sales under Rule 10b5-1 are listed for Daniel Lorrain?

The filing lists recent Rule 10b5-1 sales of CTNM common stock, including 28,826 shares on June 30, 2026, 8,353 shares on July 1, 2026, and additional smaller tranches in June and July 2026 with stated share counts and dollar amounts.

Which broker is handling the planned CTNM share sale in Daniel Lorrain's Form 144?

The proposed sale of CTNM shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with the securities to be sold on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:19 PM Accepted by SEC EDGAR 08/03/2026 - 04:18 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001861550
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CONTINEUM THERAPEUTIC INC
SEC File Number	001-42001
Address of Issuer	3565 General Atomics Court, Suite 200 San Diego CALIFORNIA 92121
Phone	8583335280
Name of Person for Whose Account the Securities are To Be Sold	Daniel Lorrain
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9520	147464.80	32958632	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/09/2017	Restricted Stock Units	Issuer			4170	05/09/2017	N/A
Common	08/03/2026	Exercise of Stock Options	Issuer			5350	08/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	07/31/2026	127	2032.00
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	07/09/2026	25	400.00
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	07/08/2026	1015	16240.00
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	07/01/2026	8353	132290.08
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/30/2026	28826	462288.02
10b5-1 Sales for DANIEL LORRAIN 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/01/2026	4170	54862.19

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	08/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Lorrain
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)